Statins Stimulate New Myocyte Formation After Myocardial Infarction by Activating Growth and Differentiation of the Endogenous Cardiac Stem Cells

The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) exert pleiotropic effects on cardiac cell biology which are not yet fully understood. Here we tested whether statin treatment affects resident endogenous cardiac stem/progenitor cell (CSC) activation in vitro and in vivo after myocardial infarction (MI). Statins (Rosuvastatin, Simvastatin and Pravastatin) significantly increased CSC expansion in vitro as measured by both BrdU incorporation and cell growth curve. Additionally, statins increased CSC clonal expansion and cardiosphere formation. The effects of statins on CSC growth and differentiation depended on Akt phosphorylation. Twenty-eight days after myocardial infarction by permanent coronary ligation in rats, the number of endogenous CSCs in the infarct border zone was significantly increased by Rosuvastatin-treatment as compared to untreated controls. Additionally, commitment of the activated CSCs into the myogenic lineage (c-kitpos/Gata4pos CSCs) was increased by Rosuvastatin administration. Accordingly, Rosuvastatin fostered new cardiomyocyte formation after MI. Finally, Rosuvastatin treatment reversed the cardiomyogenic defects of CSCs in c-kit haploinsufficient mice, increasing new cardiomyocyte formation by endogenous CSCs in these mice after myocardial infarction. In summary, statins, by sustaining Akt activation, foster CSC growth and differentiation in vitro and in vivo. The activation and differentiation of the endogenous CSC pool and consequent new myocyte formation by statins improve myocardial remodeling after coronary occlusion in rodents. Similar effects might contribute to the beneficial effects of statins on human cardiovascular diseases.

[1]  A. Cai,et al.  Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1α/CXCR-4 Axis , 2013, PloS one.

[2]  C. Kress,et al.  Spatial and temporal patterns of c-kit-expressing cells in WlacZ/+ and WlacZ/WlacZ mouse embryos. , 1996, Development.

[3]  A M Zeiher,et al.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.

[4]  C. Indolfi,et al.  Combining cell and gene therapy to advance cardiac regeneration , 2018, Expert opinion on biological therapy.

[5]  E. Marbán,et al.  c-kit+ Cells Minimally Contribute Cardiomyocytes to the Heart , 2014, Nature.

[6]  J. Molkentin,et al.  Most of the Dust Has Settled: cKit+ Progenitor Cells Are an Irrelevant Source of Cardiac Myocytes In Vivo. , 2016, Circulation research.

[7]  A. Moon,et al.  Resident c-kit+ cells in the heart are not cardiac stem cells , 2015, Nature Communications.

[8]  J. Canty,et al.  Pravastatin Improves Function in Hibernating Myocardium by Mobilizing CD133+ and cKit+ Bone Marrow Progenitor Cells and Promoting Myocytes to Reenter the Growth Phase of the Cardiac Cell Cycle , 2009, Circulation research.

[9]  R. Vasan,et al.  Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. , 2013, Blood.

[10]  D. Torella,et al.  The Absence of Evidence Is Not Evidence of Absence : The Pitfalls of Cre Knock-Ins in the C-Kit Locus , 2014 .

[11]  Y. Matsui,et al.  Pravastatin Attenuates Left Ventricular Remodeling and Diastolic Dysfunction in Angiotensin II-Induced Hypertensive Mice , 2008, Journal of cardiovascular pharmacology.

[12]  D. Torella,et al.  Role of c-Kit in Myocardial Regeneration and Aging , 2019, Front. Endocrinol..

[13]  W. Hofmann,et al.  HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes , 2003, Circulation research.

[14]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[15]  S. Dimmeler,et al.  Aging and disease as modifiers of efficacy of cell therapy. , 2008, Circulation research.

[16]  Peter Sandercock,et al.  Interpretation of the evidence for the efficacy and safety of statin therapy , 2016, The Lancet.

[17]  Mark A Sussman,et al.  Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.

[18]  Yuejin Yang,et al.  Statins and stem cell modulation , 2013, Ageing Research Reviews.

[19]  A. De Angelis,et al.  SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells. , 2015, International journal of cardiology.

[20]  D. Torella,et al.  Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Viglietto,et al.  c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration , 2019, Cell Death & Disease.

[22]  D. Torella,et al.  Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart , 2014, Nature Protocols.

[23]  P. Rabinovitch,et al.  Cardiac aging: from molecular mechanisms to significance in human health and disease. , 2012, Antioxidants & redox signaling.

[24]  D. Torella,et al.  Unravelling the Biology of Adult Cardiac Stem Cell-Derived Exosomes to Foster Endogenous Cardiac Regeneration and Repair , 2020, International journal of molecular sciences.

[25]  A. De Angelis,et al.  Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction. , 2016, International journal of cardiology.

[26]  Ciro Indolfi,et al.  Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair , 2013, Cell.

[27]  S. Fichtlscherer,et al.  Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. , 2010, Atherosclerosis.

[28]  M. Pellegrini,et al.  Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury , 2016, Cell Death and Disease.

[29]  D. Torella,et al.  Aged‐senescent cells contribute to impaired heart regeneration , 2018, bioRxiv.

[30]  J. Molkentin,et al.  Genetic Lineage Tracing of Sca-1+ Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart , 2018, Circulation.

[31]  Xiuzhen Huang,et al.  Reassessment of c-Kit+ Cells for Cardiomyocyte Contribution in Adult Heart. , 2019, Circulation.

[32]  Katsuya Iijima,et al.  Induction of Endothelial Nitric Oxide Synthase, SIRT1, and Catalase by Statins Inhibits Endothelial Senescence Through the Akt Pathway , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[33]  J. Molkentin,et al.  The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin’ Away , 2017, Circulation research.

[34]  S. Fazio,et al.  PCSK9: From Basic Science Discoveries to Clinical Trials , 2018, Circulation research.

[35]  D. Torella,et al.  Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease , 2020, Cells.

[36]  J. Isner,et al.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. , 2001, The Journal of clinical investigation.

[37]  J. Stanslas,et al.  Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians , 2017, International journal of endocrinology and metabolism.

[38]  C. Indolfi,et al.  The use and abuse of Cre/Lox recombination to identify adult cardiomyocyte renewal rate and origin , 2018, Pharmacological research.

[39]  S. Fazel,et al.  c-Kit Dysfunction Impairs Myocardial Healing After Infarction , 2007, Circulation.

[40]  A. Cumano,et al.  Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis. , 2014, Stem cells and development.

[41]  A. From,et al.  Aging Kit Mutant Mice Develop Cardiomyopathy , 2012, PloS one.

[42]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[43]  K. Frahm,et al.  Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms , 2018, PloS one.

[44]  K. Musunuru,et al.  Clinical efficacy and safety of statins in managing cardiovascular risk , 2008, Vascular health and risk management.

[45]  G. Schuler,et al.  High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study. , 2011, International journal of cardiology.

[46]  C. Indolfi,et al.  Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification , 2017, Cell Death and Differentiation.

[47]  G. Viglietto,et al.  Atrial myxomas arise from multipotent cardiac stem cells , 2020, European heart journal.

[48]  R. Rad,et al.  Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity , 2013, Nature Communications.

[49]  Yuanyuan Xie,et al.  Statin rosuvastatin inhibits apoptosis of human coronary artery endothelial cells through upregulation of the JAK2/STAT3 signaling pathway , 2020, Molecular medicine reports.

[50]  U. Laufs,et al.  Pleiotropic Effects of Statins on the Cardiovascular System , 2017, Circulation research.

[51]  Dongyin Zhang,et al.  Simvastatin ameliorates ventricular remodeling via the TGF-β1 signaling pathway in rats following myocardial infarction , 2016, Molecular medicine reports.

[52]  E. Marbán,et al.  Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.

[53]  I. Shiojima,et al.  The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. , 2000, Nature Medicine.

[54]  A. Curcio,et al.  Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor Simvastatin Prevents Cardiac Hypertrophy Induced by Pressure Overload and Inhibits p21 ras Activation , 2002, Circulation.

[55]  R. Lauro,et al.  Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients , 2005, Circulation.

[56]  E. Macchi,et al.  Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart. , 2016, American journal of physiology. Heart and circulatory physiology.

[57]  D. Torella,et al.  Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells , 2018, Cell cycle.

[58]  L. Altucci,et al.  MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat , 2016, Oncotarget.

[59]  F. Violi,et al.  Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation. , 2012, Biochemical pharmacology.

[60]  D. Lefer.  Statins as potent antiinflammatory drugs. , 2002, Circulation.

[61]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[62]  D. Torella,et al.  Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon? , 2019, Oxidative medicine and cellular longevity.

[63]  C. Indolfi,et al.  Generation of new cardiomyocytes after injury: de novo formation from resident progenitors vs. replication of pre-existing cardiomyocytes. , 2015, Annals of translational medicine.

[64]  B. Staels,et al.  Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. , 2001, The Journal of clinical investigation.

[65]  A. De Angelis,et al.  Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunction , 2017, British journal of pharmacology.

[66]  Johan Lennartsson,et al.  Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.

[67]  C. Indolfi,et al.  Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy , 2014, Journal of the American Heart Association.

[68]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[69]  C. Indolfi,et al.  Kitcre knock-in mice fail to fate-map cardiac stem cells , 2018, Nature.

[70]  R. Rosenson,et al.  Inhibition of proinflammatory cytokine production by pravastatin , 1999, The Lancet.